Clinical Trial Update: Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and PK/PD of ibuprofen liquid capsules (2 x 200 mg) for surgical removal of impacted third molars; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomatognathic Diseases
• Tooth Diseases
• Tooth Impacted

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Reckitt Benckiser Healthcare (UK) Limited | Conditions: Tooth, Impacted, Tooth Diseases | Phase 3 | Status: COMPLETED